Many people have questions about new medications. The CIMZIA FAQ will help you learn more about this medicine and how it may help you.
You can download the CIMZIA FAQ here.
You will need Adobe Acrobat Reader to view the form. You can download the latest version here.
What is CIMZIA?
CIMZIA is an injectable biologic medicine that is FDA-approved for the treatment of adults with moderately to severely active rheumatoid arthritis (RA). It is available by prescription only.
What is a biologic medicine?
A biologic is a drug that copies the effects of substances naturally made by your body's immune system. These kinds of drugs may lessen inflammation by blocking substances that cause or worsen the inflammation.
Can CIMZIA work quickly to relieve my RA symptoms?
Yes. In clinical trials, CIMZIA has been shown to reduce RA pain, stiffness, and fatigue as fast as one to two weeks for some
patients and within 6 months for most.
Can CIMZIA provide lasting relief from my RA symptoms?
Yes. In clinical trials, patients were asked how they felt at 6 months after starting treatment.
Is CIMZIA proven to slow disease progression?
Yes. In clinical trials, x-rays of patients with RA taking CIMZIA show reduction of further joint damage at both 6 months and one year.
Is CIMZIA unique?
Yes. CIMZIA is the first and only PEGylated treatment for RA. PEGylation provides a protective barrier around part of the medicine, so it can stay in your body longer and can be dosed less often. Depending on what your doctor recommends, CIMZIA can be taken as one 200 mg shot every 2 weeks or two 200 mg shots every 4 weeks after the initial 3 doses.
Click here to learn more about how CIMZIA is dosed.
How do I take CIMZIA?
CIMZIA is injected under the skin with a prefilled syringe designed in partnership with OXO Good Grips®—a company dedicated to providing consumer products to make everyday living easier. Your healthcare provider will show you how your injection is given.
Back to top
Does CIMZIA offer flexible dosing?
Yes. CIMZIA offers flexible dosing. After your initial doses, CIMZIA may be administered every two or four weeks, based on what your doctor decides is best for you.
How is CIMZIA dosed?
The recommended dose of CIMZIA for adults with RA is 400 mg (given as 2 shots that are 200 mg each) initially and at Week 2 and Week 4. After the first 3 doses, CIMZIA can be taken as one 200 mg shot every 2 weeks or two 200 mg shots every 4 weeks.
Click here to learn more about how CIMZIA is dosed.
How should I store CIMZIA, and what should I do with the used needles and syringes?
Keep CIMZIA in the refrigerator at a temperature between 36 and 46 degrees Fahrenheit (2 and 8 degrees Celsius). Be sure to let CIMZIA come to room temperature before injecting it.
Do not freeze CIMZIA. Protect CIMZIA from light and store it in the carton.
Check with your doctor for instructions on the right way to throw away your used needles and used prefilled syringes. There may be special state or local laws about throwing away used needles and syringes. Also, ask your doctor or pharmacist about how to get a puncture-proof container (a "sharps" container) that will meet the requirements of your particular state or town.
When the container is about two-thirds full, tape the lid closed. Dispose of the container as instructed by your doctor, nurse, or pharmacist. Do not throw the container in the trash or recycle. Alcohol swabs may be placed in the trash, unless you are instructed otherwise.
Always keep CIMZIA, injection supplies, puncture-proof container, and all other medicines out of the reach of children.
Can I get help paying for CIMZIA?
Yes. Taking prescription medications can be hard enough without having to worry about affording them—that is why the CIMZIA Co-Pay Savings Card program that can help patients who qualify to get up to 12 months of CIMZIA with no out-of-pocket costs. To find out more about the CIMZIA Co-Pay Savings Card program or request a CIMZIA Co-Pay Savings Card, visit
http://cimzia.com/savings/ or call 1-866-952-7968.
Is there a patient support program for CIMZIA?
Yes. CIMplicity™* is a support program designed for CIMZIA patients. CIMplicity offers services and information to help you understand as much as you can about rheumatoid arthritis and your treatment. Healthcare professionals are available to answer any questions you have about CIMZIA. To learn more or to get support right away, call 1-866-4-CIMZIA (1-866-424-6942) or visit
http://cimzia.com/savings/.
Who makes CIMZIA?
CIMZIA is made by UCB, Inc., a biopharmaceutical company with an 80-year history of worldwide innovation. UCB is passionate about enabling families with chronic diseases, such as RA, to enjoy normal, everyday lives.
Back to top
Why did UCB partner with OXO Good Grips?
UCB and OXO Good Grips partnered to create a unique, prefilled syringe designed with input from patients living with RA—so it is easy and comfortable for you to use.
What are the possible side effects of CIMZIA?
Serious infections have happened in patients taking CIMZIA, including tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections.
CIMZIA can cause serious side effects including:
Certain types of Cancer
- There have been cases of unusual cancers in children and teenage patients using TNF-blocking agents.
- For people taking TNF-blocker medicines, including CIMZIA, the chances of getting lymphoma or other cancers may increase.
- People with RA, especially more serious RA, may have a higher chance for getting a kind of cancer called lymphoma.
Heart Failure including new heart failure or worsening of heart failure you already have. Symptoms include shortness of breath, swelling of your ankles or feet, or sudden weight gain.
Nervous System Problems such as multiple sclerosis, seizures, or inflammation of the nerves of the eyes. Symptoms include dizziness, numbness or tingling, problems with your vision, and weakness in your arms or legs.
Allergic Reactions. Signs of an allergic reaction include a skin rash, swelling of the face, tongue, lips, or throat, or trouble breathing.
Hepatitis B virus reactivation in patients who carry the virus in their blood. In some cases patients have died as a result of hepatitis B virus being reactivated. Your doctor should monitor you carefully during treatment with CIMZIA if you carry the hepatitis B virus in your blood. Tell your doctor if you have any of the following symptoms:
- feel unwell
- poor appetite
- tiredness (fatigue)
- fever, skin rash, or joint pain
Blood Problems. Your body may not make enough of the blood cells that help fight infections or help stop bleeding. Symptoms include a fever that doesn't go away, bruising or bleeding very easily, or looking very pale.
Immune reactions including a lupus-like syndrome. Symptoms include shortness of breath, joint pain, or a rash on the cheeks or arms that worsens with sun exposure.
Call your doctor right away if you develop any of the above side effects or symptoms.
The most common side effects of CIMZIA are: upper respiratory infections (flu, cold), rash, and urinary tract infections (bladder infections).
Other side effects have happened in some people including new psoriasis or worsening of psoriasis you already have and injection-site reactions. Tell your doctor about any side effect that bothers you or does not go away. These are not all of the side effects with CIMZIA. Ask your doctor or pharmacist for more information.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
Please see the Medication Guide for CIMZIA and discuss it with your doctor.
Back to top